Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
3 drugs in this class with 39,965 total adverse event reports.
3 Drugs
39,965 Total Reports
20,404 Serious Reports
8,719 Death Reports
| # | Drug Name | Generic Name | Reports | Serious | Deaths |
|---|---|---|---|---|---|
| 1 | Valganciclovir | VALGANCICLOVIR | 18,446 | 9,178 | 3,190 |
| 2 | Basiliximab | BASILIXIMAB | 11,495 | 5,585 | 2,448 |
| 3 | Ganciclovir | GANCICLOVIR | 10,024 | 5,641 | 3,081 |